VRCA Past Earnings image Verrica Pharmaceuticals Past Earnings

VRCA Past Earnings

— Presenting past earnings and revenue for Verrica Pharmaceuticals (VRCA) from Q3 2018 to Q2 2026, based on our latest update on 8/12/2026. The past earnings numbers are per-share values while the revenue is the grand total for the quarter. Studying these VRCA past earnings numbers both in chart format and in tables can help investors visualize any typical seasonality patterns, as well as determine whether the company has grown over time.
Quick links: Past Earnings  |  Past Revenue  |  FAQ
VRCA Past Earnings
PeriodPast Earnings DateAdj. EPS
Q2 20268/6/2026-0.480
Q1 20265/12/2026-0.410
Q4 20253/11/2026-0.510
Q3 202511/14/20250.130
Q2 20258/12/20250.250
Q1 20255/13/2025-0.800
Q4 20243/11/2025-1.800
Q3 202411/4/2024-4.300
Q2 20248/14/2024-3.100
Q1 20245/13/2024-3.800
Q4 20232/29/2024-5.300
Q3 202311/9/2023-3.200
Q2 20238/8/2023-2.100
Q1 20235/9/2023-1.300
Q4 20223/6/2023-1.400
Q3 202211/7/20220.700
Q2 20228/11/2022-3.700
Q1 20225/9/2022-2.500
Q4 20213/2/2022-3.500
Q3 202111/12/2021-4.700
Q2 20218/10/2021-4.300
Q1 20215/7/2021-4.000
Q4 20203/4/2021-5.200
Q3 202011/9/2020-4.200
Q2 20208/5/2020-3.800
Q1 20205/7/2020-3.900
Q4 20193/13/2020-3.100
Q3 201911/6/2019-2.400
Q2 20198/7/2019-2.800
Q1 20195/7/2019-3.000
Q4 20183/7/2019-3.000
Q3 201811/7/2018-2.700
VRCA Past Revenue
PeriodPast Earnings DateGAAP
Q2 20268/6/20260.01B
Q1 20265/12/20260.01B
Q4 20253/11/20260.01B
Q3 202511/14/20250.01B
Q2 20258/12/20250.01B
Q1 20255/13/20250.00B
Q4 20243/11/20250.00B
Q3 202411/4/2024-0.00B
Q2 20248/14/20240.01B
Q1 20245/13/20240.00B
Q4 20232/29/20240.00B
Q3 202311/9/20230.00B
Q2 20238/8/20230.00B
Q1 20235/9/20230.04M
Q4 20223/6/20230.07M
Q3 202211/7/20220.01B
Q2 20228/11/20220.00B
Q1 20225/9/20220.00B
Q4 20213/2/2022NA
Q3 202111/12/2021NA
Q2 20218/10/2021NA
Q1 20215/7/20210.01B
Q4 20203/4/2021NA
Q3 202011/9/2020NA
Q2 20208/5/2020NA
Q1 20205/7/2020NA
Q4 20193/13/2020NA
Q3 201911/6/2019NA
Q2 20198/7/2019NA
Q1 20195/7/2019NA
Q4 20183/7/2019NA
Q3 201811/7/2018NA
Quotes delayed 20 minutes

Email EnvelopeFree VRCA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Verrica Pharmaceuticals (VRCA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

VRDN Past Earnings
VREX Past Earnings
VRPX Past Earnings
VRTX Past Earnings
VSTM Past Earnings
VTGN Past Earnings
VTRS Past Earnings
VTVT Past Earnings
VTYX Past Earnings
VVOS Past Earnings

VRCA Past Earnings Q&A

What was the best and worst VRCA past earnings results?
For Verrica Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest VRCA past earnings result in our data set was 0.700/share posted in Q3 2022, while the lowest was in Q4 2023 when VRCA posted -5.300/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2025 when VRCA reported 0.01B in revenue, while the quarter with the lowest revenue in our data set was Q3 2024 at -0.00B of revenue.

  Suggested answer: There are 32 VRCA past earnings results in our data set.

On this page we presented the VRCA past earnings date information for Verrica Pharmaceuticals. Reviewing that VRCA Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2022, when VRCA posted adjusted EPS of 0.700/share. Meanwhile the lowest VRCA past earnings result was in Q4 2023, when VRCA posted adjusted EPS of -5.300/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2025 when VRCA reported 0.01B in revenue, while the smallest revenue quarter was Q3 2024 when VRCA reported -0.00B in revenue.

Any self directed investor doing their due diligence on VRCA or any other given stock can benefit from researching all of the Verrica Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Verrica Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for VRCA. Thanks for visiting, and the next time you need to research VRCA past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.
 

VRCA Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2026, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.